In recent times there has been some interest in the KRTL Holding Group Inc. (OTC: KRTL) stock among investors, and on Wednesday the company had in fact been in the news following a key announcement. Yesterday the company hit the news cycle after it made an announcement with regard to its business in Bolivia.
The Update
In the news release from the company on Wednesday, it was announced that two of its subsidiaries, KRTL International Corp and KRTL Biotech Inc., had established a joint venture in Bolivia with Centro de Investigaciones Quimicas CIQ S R L. Centro de Investigaciones is a major Bolivian manufacturing and research institution headed by Dr. Bascope, who is widely noted for his work in the biopharmaceutical sector. KRTL Holding Group also stated yesterday that the move was also a demonstration of the company’s considerable belief in the vast potential in Bolivia.
Further Information
The company noted that over the past decades, the worldwide supply chain of the pharmaceutical industry had been dominated by China and India. However, the evolution of the economic dynamics and a thrust towards sustainability had created considerable opportunities for countries like Bolivia, which boast of significant natural resources and production at competitive costs.
Management Quote
Dr. Bascope, a renowned scientist and visionary in the field, sees this partnership as an evolution in sustainable pharmaceutical production. “This joint venture expands CIQ’s potential far beyond Bolivia, allowing us to introduce our botanical extracts and APIs to new markets while advancing scientific research through KRTL Biotech’s regulatory expertise,” said Dr. Bascope.
